1-3 of 3
Authors: Mari Ariyasu
Journal Article
Pathogen-focused Clinical Development to Address Unmet Medical Need: Cefiderocol Targeting Carbapenem Resistance Open Access
Clinical Infectious Diseases, Volume 69, Issue Supplement_7, 1 December 2019, Pages S559–S564, https://doi.org/10.1093/cid/ciz829
Published: 13 November 2019
Journal Article
Compassionate Use of Cefiderocol as Adjunctive Treatment of Native Aortic Valve Endocarditis Due to Extremely Drug-resistant Pseudomonas aeruginosa Open Access
Clinical Infectious Diseases, Volume 68, Issue 11, 1 June 2019, Pages 1932–1934, https://doi.org/10.1093/cid/ciy963
Published: 12 November 2018
Journal Article
Developing Outcomes Assessments as Endpoints for Registrational Clinical Trials of Antibacterial Drugs: 2015 Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health Free
Clinical Infectious Diseases, Volume 62, Issue 5, 1 March 2016, Pages 603–607, https://doi.org/10.1093/cid/civ927
Published: 13 December 2015
